PapersPMID:16856052
Magnesium supplementation for the management of essential hypertension in adults.
What moved
1 findingHow to read these marks →- Decreases diastolic blood pressure
very limitedreplicated ×6
“Combining all trials, participants receiving magnesium supplements as compared to control did not significantly reduce SBP (mean difference: -1.3 mmHg, 95% CI: -4.0 to 1.5, I(2)=67%), but did statistically significantly reduce DBP (mean difference: -2.2 mmHg, 95% CI: -3.4 to -0.9, I(2)=47%).”
- Study
- meta-analysis
- Effect
- −2.2 mean difference, 95% CI −3.4 to −0.9
- Dose studied
- oral magnesium supplementation, doses varied across trials
- Population
- Adults with primary hypertension; pooled randomized trials of oral magnesium supplementation versus placebo, no treatment or usual care
Study record
- Design
- meta-analysis
- Species
- human
- Population
- 12 RCTs (n=545), adults with primary hypertension, 8-26 weeks follow-up
- Participants
- 545
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 2
magnesium(2+)